Volume 13 - Articles-1402                   MEJDS (2023) 13: 66 | Back to browse issues page

Research code: 162293043
Ethics code: 162293043

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Farhady A, Sodani M, Gholamzadeh Jofreh M. Determining the Effectiveness of Schema Therapy on Life Quality and Anxiety of Rehabilitated Addicts under Methadone Therapy in Ahvaz City, Iran. MEJDS 2023; 13 :66-66
URL: http://jdisabilstud.org/article-1-2802-en.html
Determining the Effectiveness of Schema Therapy on Life Quality and Anxiety of Rehabilitated Addicts under Methadone Therapy in Ahvaz City, Iran
Ahmad Farhady1 , Mansour Sodani *2 , Maryam Gholamzadeh Jofreh3
1- PhD Student in Counseling, Department of Counseling, Ahvaz Branch, Islamic Azad University, Ahvaz, Iran
2- Professor, Department of Counseling, Shahid Chamran University of Ahvaz, Ahvaz, Iran
3- Assistant Professor, Counseling Department, Ahvaz Branch, Islamic Azad University, Ahvaz, Iran
Abstract:   (936 Views)

Abstract
Background & Objectives: Addiction is one of the most important problems of human society. The problem has emerged as pervasive and endangered millions of people's lives. Every year, governments spend large national capital to combat this ominous phenomenon. Anxiety, depression, and maladaptive schemas formed in childhood are cited as important and influential factors in the development and continuance of drug use. Research has shown that people suffering from mental disorders such as anxiety and mood disorders are more likely to get addicted than the general population. Also, drug addicts suffer more from mood disorders and anxiety than the general population. One of the effective psychological treatments to adjust cognitive, emotional, emotional, and behavioral experiences in drug abusers is schema therapy. This study aimed to investigate the effect of schema therapy on the life quality and anxiety of recovered addicts using methadone referring to addiction treatment centers in Ahvaz City, Iran.

Methods: The present study was conducted by quasi–experimental method with a pretest–posttest and follow–up design employing a control group. The statistical population included all drug users referred to welfare–related medical centers in Ahvaz from March 2020 to March 2021. For the present study, one center was chosen with 40 individuals. They were randomly selected and assigned to the experimental and control (each group=20). The inclusion criteria included male individuals aged 20 to 50 years who had not participated in other psychological treatments without obvious physical and mental illness. The exclusion criteria were individuals who failed to cooperate in any research stages or did not attend the training sessions. The World Health Organization Quality of Life (WHOQOL–BREF) Questionnaire (1996) brief form and Four Systems Anxiety Questionnaire (FSAQ) (Koksal & Power, 1990) were used to collect data. The experimental group received 12 sessions (each lasting 95 minutes) of schema therapy, and the control group continued drug therapy without psychological intervention according to the center's routine. In the current research, data analysis was done using SPSS version 22 software in descriptive and inferential statistics. At the level of descriptive statistics, mean and standard deviation were used. Then, multivariate and univariate analyses of covariance tests were used to analyze the data at a significance level of 0.05.

Results: The multivariate covariance analysis indicated that schema therapy significantly affected at least one of the variables of quality of life and anxiety in the experimental group (p<0.01). The eta coefficient was 0.91. The results of univariate covariance analysis indicated that, after removing the effect of the pretest, the differences between the experimental group and the control group were significant in the quality of life (p<0.001) and anxiety (p<0.001) variables in the posttest. Schema therapy (independent variable) contributed 90% to increasing the quality of life and 92% to reducing anxiety.

Conclusion: Schematic therapy increases the quality of life and reduces the anxiety of recovering addicts using methadone in Ahvaz, and this treatment can be used in addiction treatment centers.

Keywords: Schema therapy, Anxiety, Quality of life, Rehabilitated addicts under methadone therapy
Full-Text [PDF 497 kb]   (381 Downloads)    
Type of Study: Original Research Article | Subject: Rehabilitation
References
1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM–5. 5th ed. Washington, D.C: American Psychiatric Association; 2013.
2. Najavits LM, Hyman SM, Ruglass LM, Hien DA, Read JP. Substance use disorder and trauma. In: APA handbook of trauma psychology: foundations in knowledge, Vol 1. Washington, DC, US: American Psychological Association; 2017. pp: 195–213. [DOI]
3. Jupp B, Dalley JW. Behavioral endophenotypes of drug addiction: etiological insights from neuroimaging studies. Neuropharmacology. 2014;76 Pt B:487–97. [DOI]
4. Sadock BJ, Sadock VA, Ruiz P. Kaplan & Sadock's synopsis of psychiatry: behavioral sciences/clinical psychiatry. 9th ed. Philadelphia: Wolters Kluwer; 2007.
5. Prior K, Mills K, Ross J, Teesson M. Substance use disorders comorbid with mood and anxiety disorders in the Australian general population. Drug Alcohol Rev. 2017;36(3):317–24. [DOI]
6. McKay JR. Lessons learned from psychotherapy research. Alcohol: Clinical and Experimental Research. 2007;31(s3):48s–54s. [DOI]
7. Tucker JA, Donovan DM, Marlatt GA, Glaser FB. Changing addictive behavior: bridging clinical and public health strategies. New York: Guilford Publications; 1999.
8. Ghandehari A, Dehghani A. Effectiveness of group schema therapy in metacognitive beliefs and methadone dose reduction in men under methadone treatment. Scientific Quarterly Research on Addiction. 2018;11(44):169–86. [Persian] [Article]
9. Mohagheghi H, Kharghani P. The effect of schema therapy on anxiety, depression, and early maladaptive schemas in individuals with substance use disorder. Scientific Quarterly Research on Addiction. 2021;15(60):299–324. [Persian] [DOI]
10. Young JE, Klosko JS, Weishaar ME. Schema therapy: a practitioner's guide. 1st ed. New York: Guilford Press; 2006.
11. Graaf P, Holt RA, Loose C, Zarbock G. Schema therapy with children and adolescents: a practitioner's guide. Pavilion Publishing and Media Ltd; 2020.
12. van Dijk SDM, Veenstra MS, Bouman R, Peekel J, Veenstra DH, van Dalen PJ, et al. Group schema–focused therapy enriched with psychomotor therapy versus treatment as usual for older adults with cluster B and/or C personality disorders: a randomized trial. BMC Psychiatry. 2019;19(1):26. [DOI]
13. Purmohammad V, Yaghoubi H, Yousefi R, Mohammadzadeh A, Najafi M. The comparison of maladaptive schema and lifestyles in drug dependence and non–drug dependence people. Scientific Quarterly Research on Addiction. 2013;7(27):107–24. [Persian] [Article]
14. Young JE. Cognitive therapy for personality disorders: a schema-focused approach. 3rd ed. Sarasota, Fla: Professional Resource Press; 1999.
15. Ball SA, Young JE. Dual focus schema therapy for personality disorders and substance dependence: case study results. Cognitive and Behavioral Practice. 2000;7(3):270–81. [DOI]
16. Shorey RC, Stuart GL, Anderson S, Strong DR. Changes in early maladaptive schemas after residential treatment for substance use. J Clin Psychol. 2013;69(9):912–22. [DOI]
17. Delavar A. Educational and psychological research. Tehran: Virayesh Pub; 2019.
18. World Health Organization. WHOQOL–BREF : introduction, administration, scoring and generic version of the assessment : field trial version, December 1996 [Internet]. World Health Organization, Division of Mental Health; 1996. Report No.: WHOQOL–BREF. Available from: [Article]
19. Mohtadijafari S, Ashayeri H, Banisi P. The effectiveness of schema therapy techniques in mental health and quality of life of women with premenstrual dysphoric disorder. Iranian Journal of Psychiatry and Clinical Psychology. 2019;25(3):278–91. [Persian] [DOI]
20. Nejat S, Montazeri A, Holakouie Naieni K, Mohammad K, Majdzadeh SR. The World Health Organization Quality of Life (WHOQOL-BREF) Questionnaire: translation and validation study of the Iranian version. Journal of School of Public Health and Institute of Public Health Research. 2006;4(4):1–12. [Persian] [Article]
21. Koksal F, Power KG. Four Systems Anxiety Questionnaire (FSAQ): a self–report measure of somatic, cognitive, behavioral, and feeling components. J Pers Assess. 1990;54(3–4):534–45. [DOI]
22. Maredpour AR, Shaeeiri MR, Kafi M. The study of psychometric properties, the Four System Anxiety Questionnaire (FSAQ). Clinical Psychology and Personality. 2010;8(2):11–20. [Persian] [Article]
23. Arntz A, Jacob G. Schema therapy in practice: an introductory guide to the schema mode approach. Chichester, West Sussex ; Malden, MA: John Wiley & Sons Inc; 2013.
24. Farrell JM, Shaw IA. Experiencing schema therapy from the inside out: a self-practice/self–reflection workbook for therapists. New York: Guilford Press; 2018.
25. Farrell JM, Reiss N, Shaw IA. The schema therapy clinician's guide: a complete resource for building and delivering individual, group and integrated schema mode treatment programs. Oxford: John Wiley & Sons, Ltd; 2014. [DOI]
26. Heath G. Creative methods in schema therapy: advances and innovation in clinical practice. London ; New York: Routledge/Taylor & Francis Group; 2020.
27. Oraki M, Dortaj A, Mahdizadeh A. Effectiveness of schema therapy in early maladaptive schemas and insecure attachment styles in heroin dependent people. Scientific Quarterly Research on Addiction. 2018;12(46):37–54. [Persian] [Article]
28. Ekhtiari H, Norouzi A, Daneshmand R, Maarefvand M, Jourghanian P, Farhoudian A, et al. Inpatient services in addiction treatment: a review on evidences. Tehran: Mehrsa Pub; 2010, pp: 11–100. [Persian]
29. Shorey RC, Anderson S, Stuart GL. Early maladaptive schemas in substance use patients and their intimate partners: a preliminary investigation. Addict Disord Their Treat. 2011;10(4):169–79. [DOI]
Add your comments about this article : Your username or Email:
CAPTCHA
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Middle Eastern Journal of Disability Studies

Designed & Developed by : Yektaweb